The American Journal of Managed Care
FDA Approves Another OTC Naloxone Nasal Spray for Opioid Overdose
Rextovy joins Narcan and RiVive as OTC intranasal naloxone options, enabling layperson administration and potentially improving time-to-reversal in community settings. US overdose epidemiology shows a ...
Medical Xpress
FDA approves another over-the-counter naloxone nasal spray
"Reducing opioid overdose deaths is a top priority for the FDA," Mike Davis M.D., Ph.D., from the FDA Center for Drug Evaluation and Research, said in a statement. "Today's approval of an additional ...
RAPS
FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose Treatment
Teva Pharmaceuticals USA snagged US Food and Drug Administration (FDA) final approval for the first generic naloxone hydrochloride nasal spray known as Narcan, the agency announced on Friday. The life ...
Yahoo
FDA approves new OTC overdose-reversing nasal spray
Add Yahoo as a preferred source to see more of our stories on Google. WASHINGTON (KTAL/KMSS) — The U.S. Food and Drug Administration has approved another over-the-counter naloxone nasal spray that can ...
katc
FDA approves nonprofit's over-the-counter opioid overdose nasal spray
The U.S. Food and Drug Administration approved another over-the-counter naloxone nasal spray used to reverse opioid overdose on Friday. RiVive, made by Harm Reduction Therapeutics, is the second ...
The Hill
FDA approves third over-the-counter opioid overdose nasal spray
The Food and Drug Administration (FDA) approved a third over-the-counter version of naloxone nasal spray Tuesday, in a move the agency said could save lives and reduce costs. The agency approved ...